Official Launch of Korean transparent orthodontic brand ZTA Transalign in Thailand

Food and Healthcare Press Releases Wednesday March 28, 2018 17:18
Bangkok--28 Mar--Four Hundred
Zeniton Thailand hosts a launch seminar at Hilton Sukhumvit Hotel Bangkok
Zeniton Thailand officially launches clear aligner, ZTA Trans-align from Korea, at Hilton Sukhumvit hotel in Bangkok, Thailand on 23rd.
ZTA Trans-align, made of special plastic, is an orthodontic clear aligner brand made by orthodontists with long orthodontic experience in dentistry and digitalized 3D printer.

This seminar was attended by 200 Thai dentists not only proceeded to share the ZTA-Trans-align's vision and value but also to conduct dental information exchange session for clear aligner system and correction method.

At the seminar, Lee Jong Kuk, Chief of ZTA consulting group explained the merits of ZTA Trans-align under the topic of New Paradigm of Clear Aligner and Natenapaporn Amonpatmethakul, representative of Zeniton Thailand introduced about Zeniton Thailand.

At the press conference ahead of the seminar, the leader of the Korean girl group "Hashtag" Da-Jung, attended as an exclusive model of ZTA Trans-align. In addition, Aum Yong Sup, Honorary president of the Korea Entertainment Producer's Association, said, "We will actively participate in ZTA Trans-align global marketing and Happy Smile Dental Bus service activities through K-POP Star with cooperation between the Zeniton Group."

About ZTA-Trans align
Advantages

ZTA Trans-align is a new clear aligning method using a personalized ZTA clear aligner made by specialized clear material. The ZTA Consulting Group with more than 10 years of experience, has developed diagnostic and treatment plans for orthodontic patients and has developed a step-by-step aligning model through 3D printers and software bringing highly affective orthodontic appliances as a return.

ZTA Trans-align are widely used because they can be customized individually; differentiated from general clear aligner devices. Aesthetics are also considered, so there is a high degree of preference and less pain with less irritation

About Zeniton

Established in 2009, Zeniton is the Korea's leading oral healthcare company founded by dentists gathered to perform "human-centered care." In accordance with the philosophy of product development to 'provide products that my family can use', we exclude the unsecured ingredients and replace the chemical ingredients to natural ingredients as much as possible.

Our oral health business researches and develops oral health products such as infant toothpaste, infant candy, adult toothpaste, toothbrush. The "Happy Smile Dental Bus" is a social contribution project that provides medical care services for the underprivileged.

About Zenitoni

Zenitoni Co., LTD is a distributor for OEM development and professional distribution of dental materials. With all the staff working hard in unison to provide the best product and the excellent service to dentists and patients all over the world. Zenitoni also focuses to fulfil the social responsibilities with Zeniton by continuously supporting dental care for the underprivileged in Korea. Zenitoni is not only planning to domestically support the underprivileged but to expand the service worldwide.


Latest Press Release

Michel Orsinger Assumes Role as Chairman of Limacorporate#s Advisory Board

LimaCorporate is pleased to announce that Michel Orsinger, Board Member of LimaCorporate's Advisory Board, will assume the role of Chairman of the Board. Michel joined the Advisory Board mid-2017 following a long and successful global career in...

Merck and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer

Merck and Pfizer Inc. (NYSE: PFE) today announced that the Phase III JAVELIN Ovarian 200 trial evaluating avelumab* alone or in combination with pegylated liposomal doxorubicin (PLD), a type of chemotherapy, compared with PLD did not meet the...

APEC#s Rare Disease Action Plan Sets Precedent to Integrate Rare Disease Care by 2025

- Asia-Pacific Economic Cooperation (APEC) Life Sciences Innovation Forum (LSIF) Rare Disease Network comprises Rare Disease International, Queensland University of Technology and Shire (representing as industry co-chair). - Aims to define, diagnose and...

Grunenthal Acquires Averitas Pharma and Establishes Commercial Footprint in the US

Grunenthal announced today that it has acquired the US-based pharmaceutical company Averitas Pharma, thereby extending its commercial footprint to the United States. Averitas Pharma will be commercialising the pain patch Qutenza(R) (8 % capsaicin) for...

Ascensia Diabetes Care Highlights the Support That Families Provide for People With Diabetes To Mark World Diabetes Day 2018

Today, Ascensia Diabetes Care, a global leading diabetes care company, launched their campaign for World Diabetes Day 2018 to celebrate the important role of families for people with diabetes. They are publishing 38 online artworks that tell the stories...

Related Topics